药品注册申请号:018553
申请类型:NDA (新药申请)
申请人:ANI PHARMS
申请人全名:ANI PHARMACEUTICALS INC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 INDERAL LA PROPRANOLOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 160MG Yes Yes AB 1983/04/19 1983/04/19 Prescription
002 INDERAL LA PROPRANOLOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 80MG Yes No AB 1983/04/19 Prescription
003 INDERAL LA PROPRANOLOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 120MG Yes No AB 1983/04/19 Prescription
004 INDERAL LA PROPRANOLOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 60MG Yes No AB 1987/03/18 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2023/11/07 SUPPL-52(补充) Approval Labeling STANDARD
2023/11/07 SUPPL-48(补充) Approval Manufacturing (CMC) STANDARD
2015/12/21 SUPPL-39(补充) Approval Manufacturing (CMC) STANDARD
2015/10/22 SUPPL-38(补充) Approval Manufacturing (CMC) STANDARD
2011/03/17 SUPPL-37(补充) Approval Labeling UNKNOWN
2007/10/31 SUPPL-36(补充) Approval Labeling STANDARD
2007/02/21 SUPPL-35(补充) Approval Labeling STANDARD
2007/01/03 SUPPL-34(补充) Approval Labeling STANDARD
2004/06/09 SUPPL-30(补充) Approval Labeling STANDARD
2002/02/06 SUPPL-29(补充) Approval Labeling STANDARD
2000/03/31 SUPPL-28(补充) Approval Manufacturing (CMC) STANDARD
1999/08/22 SUPPL-27(补充) Approval Labeling STANDARD
1997/11/07 SUPPL-26(补充) Approval Labeling STANDARD
1990/04/17 SUPPL-25(补充) Approval Manufacturing (CMC) STANDARD
1990/02/09 SUPPL-24(补充) Approval Manufacturing (CMC) STANDARD
1989/07/10 SUPPL-23(补充) Approval Manufacturing (CMC) STANDARD
1989/06/05 SUPPL-22(补充) Approval Manufacturing (CMC) STANDARD
1989/04/10 SUPPL-21(补充) Approval Manufacturing (CMC) STANDARD
1989/01/25 SUPPL-20(补充) Approval Manufacturing (CMC) STANDARD
1988/08/08 SUPPL-19(补充) Approval Manufacturing (CMC) STANDARD
1988/05/25 SUPPL-18(补充) Approval Manufacturing (CMC) STANDARD
1987/03/18 SUPPL-13(补充) Approval Efficacy
1987/01/20 SUPPL-17(补充) Approval Manufacturing (CMC) STANDARD
1986/09/02 SUPPL-16(补充) Approval Manufacturing (CMC) STANDARD
1986/05/27 SUPPL-15(补充) Approval Manufacturing (CMC) STANDARD
1986/03/04 SUPPL-12(补充) Approval Manufacturing (CMC) STANDARD
1986/01/07 SUPPL-9(补充) Approval Manufacturing (CMC) STANDARD
1985/11/20 SUPPL-11(补充) Approval Manufacturing (CMC) STANDARD
1985/08/20 SUPPL-8(补充) Approval Efficacy
1985/04/02 SUPPL-10(补充) Approval Manufacturing (CMC) STANDARD
1985/03/21 SUPPL-6(补充) Approval Labeling
1984/10/11 SUPPL-4(补充) Approval Manufacturing (CMC) STANDARD
1984/08/09 SUPPL-5(补充) Approval Manufacturing (CMC) STANDARD
1984/03/06 SUPPL-2(补充) Approval Manufacturing (CMC) STANDARD
1984/01/09 SUPPL-1(补充) Approval Efficacy
1983/04/19 ORIG-1(原始申请) Approval Type 3 - New Dosage Form STANDARD
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:PROPRANOLOL HYDROCHLORIDE 剂型/给药途径:CAPSULE, EXTENDED RELEASE;ORAL 规格:160MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
018553 001 NDA INDERAL LA PROPRANOLOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 160MG Prescription Yes Yes AB 1983/04/19 ANI PHARMS
078065 004 ANDA PROPRANOLOL HYDROCHLORIDE PROPRANOLOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 160MG Prescription No No AB 2007/01/26 NORTEC DEV ASSOC
078494 004 ANDA PROPRANOLOL HYDROCHLORIDE PROPRANOLOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 160MG Prescription No No AB 2007/08/10 ACTAVIS ELIZABETH
090321 004 ANDA PROPRANOLOL HYDROCHLORIDE PROPRANOLOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 160MG Prescription No No AB 2011/03/25 ZYDUS PHARMS USA INC
078703 004 ANDA PROPRANOLOL HYDROCHLORIDE PROPRANOLOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 160MG Prescription No No AB 2011/07/15 ADARE PHARMS INC
212026 004 ANDA PROPRANOLOL HYDROCHLORIDE PROPRANOLOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 160MG Prescription No No AB 2020/01/06 AMTA
204349 004 ANDA PROPRANOLOL HYDROCHLORIDE PROPRANOLOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 160MG Discontinued No No AB 2024/01/12 LUPIN LTD
活性成分:PROPRANOLOL HYDROCHLORIDE 剂型/给药途径:CAPSULE, EXTENDED RELEASE;ORAL 规格:80MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
018553 002 NDA INDERAL LA PROPRANOLOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 80MG Prescription Yes No AB 1983/04/19 ANI PHARMS
078065 002 ANDA PROPRANOLOL HYDROCHLORIDE PROPRANOLOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 80MG Prescription No No AB 2007/01/26 NORTEC DEV ASSOC
078494 002 ANDA PROPRANOLOL HYDROCHLORIDE PROPRANOLOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 80MG Prescription No No AB 2007/08/10 ACTAVIS ELIZABETH
090321 002 ANDA PROPRANOLOL HYDROCHLORIDE PROPRANOLOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 80MG Prescription No No AB 2011/03/25 ZYDUS PHARMS USA INC
078703 002 ANDA PROPRANOLOL HYDROCHLORIDE PROPRANOLOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 80MG Prescription No No AB 2011/07/15 ADARE PHARMS INC
212026 002 ANDA PROPRANOLOL HYDROCHLORIDE PROPRANOLOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 80MG Prescription No No AB 2020/01/06 AMTA
204349 002 ANDA PROPRANOLOL HYDROCHLORIDE PROPRANOLOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 80MG Discontinued No No AB 2024/01/12 LUPIN LTD
活性成分:PROPRANOLOL HYDROCHLORIDE 剂型/给药途径:CAPSULE, EXTENDED RELEASE;ORAL 规格:120MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
018553 003 NDA INDERAL LA PROPRANOLOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 120MG Prescription Yes No AB 1983/04/19 ANI PHARMS
078065 003 ANDA PROPRANOLOL HYDROCHLORIDE PROPRANOLOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 120MG Prescription No No AB 2007/01/26 NORTEC DEV ASSOC
078494 003 ANDA PROPRANOLOL HYDROCHLORIDE PROPRANOLOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 120MG Prescription No No AB 2007/08/10 ACTAVIS ELIZABETH
090321 003 ANDA PROPRANOLOL HYDROCHLORIDE PROPRANOLOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 120MG Prescription No No AB 2011/03/25 ZYDUS PHARMS USA INC
078703 003 ANDA PROPRANOLOL HYDROCHLORIDE PROPRANOLOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 120MG Prescription No No AB 2011/07/15 ADARE PHARMS INC
212026 003 ANDA PROPRANOLOL HYDROCHLORIDE PROPRANOLOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 120MG Prescription No No AB 2020/01/06 AMTA
204349 003 ANDA PROPRANOLOL HYDROCHLORIDE PROPRANOLOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 120MG Discontinued No No AB 2024/01/12 LUPIN LTD
活性成分:PROPRANOLOL HYDROCHLORIDE 剂型/给药途径:CAPSULE, EXTENDED RELEASE;ORAL 规格:60MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
018553 004 NDA INDERAL LA PROPRANOLOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 60MG Prescription Yes No AB 1987/03/18 ANI PHARMS
078065 001 ANDA PROPRANOLOL HYDROCHLORIDE PROPRANOLOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 60MG Prescription No No AB 2007/01/26 NORTEC DEV ASSOC
078494 001 ANDA PROPRANOLOL HYDROCHLORIDE PROPRANOLOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 60MG Prescription No No AB 2007/08/10 ACTAVIS ELIZABETH
090321 001 ANDA PROPRANOLOL HYDROCHLORIDE PROPRANOLOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 60MG Prescription No No AB 2011/03/25 ZYDUS PHARMS USA INC
078703 001 ANDA PROPRANOLOL HYDROCHLORIDE PROPRANOLOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 60MG Prescription No No AB 2011/07/15 ADARE PHARMS INC
212026 001 ANDA PROPRANOLOL HYDROCHLORIDE PROPRANOLOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 60MG Prescription No No AB 2020/01/06 AMTA
204349 001 ANDA PROPRANOLOL HYDROCHLORIDE PROPRANOLOL HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL 60MG Discontinued No No AB 2024/01/12 LUPIN LTD
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database